Listed pharmas getting better with cash flow

It was researched listed pharmaceutical companies had 35% increased cash flow for operating activities.

According to the Yakup Shinmoon’s(www.yakup.com) analysis result of listed pharmaceutical companies’ 2016 audit reports(consolidated), their cash flow for operating activities was KRW 1.1951 trillion increased by 35.2% from KRW 884.2 billion in 2015. (holding and biotechnology companies excl...